000 | 01415 a2200337 4500 | ||
---|---|---|---|
005 | 20250515180239.0 | ||
264 | 0 | _c20091014 | |
008 | 200910s 0 0 eng d | ||
022 | _a1747-3667 | ||
024 | 7 |
_a10.1097/01.hjh.0000357907.68402.99 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrari, Roberto | |
245 | 0 | 0 |
_aCardiovascular protection: a breakthrough for high-risk patients? _h[electronic resource] |
260 |
_bJournal of hypertension. Supplement : official journal of the International Society of Hypertension _cJul 2009 |
||
300 |
_aS37-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
650 | 0 | 4 |
_aBenzoates _xpharmacology |
650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xcomplications |
650 | 0 | 4 |
_aRamipril _xpharmacology |
650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTelmisartan |
773 | 0 |
_tJournal of hypertension. Supplement : official journal of the International Society of Hypertension _gvol. 27 _gno. 5 _gp. S37-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.hjh.0000357907.68402.99 _zAvailable from publisher's website |
999 |
_c19002588 _d19002588 |